Current research
At ANSTO, radiopharmaceutical development facilities are available to researchers and industry through peer-reviewed, collaborative and commercial arrangements. ANSTO LifeScience's radiopharmaceutical development facilities include: Radiopharmaceuticals chemistry, pharmacology, PET/CT and SPECT/CT
Clinical and research communities interested in gaining access to specific radionuclides are welcome to discuss their needs with ANSTO LifeSciences. For example, the organisation has developed a technique for producing carrier free lutetium-177.
ANSTO LifeSciences' main research areas are:
Radiopharmaceuticals
Animal imaging is the most important means of validating a radiopharmaceutical before clinical trials.
Radionuclide development
Developing and supplying non-conventional radionuclides to the medical community.
Pre-clinical imaging
Pre-clinical imaging, using PET imaging and SPECT imaging technologies.